Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

PJ Online | News: Short antibiotic courses can treat children’s urinary tract infections

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7212 p241
24 August 2002

This article

News summary

Related websites
Archives of Disease in Childhood article (more)

Short antibiotic courses can treat children’s urinary tract infections

A course of oral antibiotics lasting two to four days is just as effective at eradicating urinary tract infections (UTIs) in children as standard treatment over seven to 14 days, a new study shows (Archives of Disease in Childhood 2002;87:118).

Australian researchers analysed data from 10 randomised controlled trials. They found there was no difference in the frequency of positive urine cultures or in the number of recurrent UTIs among children who had received a standard course of antibiotics lasting one to two weeks and those who had received only two to four days of treatment. In addition, there was no difference in the development of resistant organisms in the two treatment groups. The researchers say that statistical imprecision in the study means it does not provide incontrovertible evidence that short duration therapy is better. However, they suggest this imprecision is of doubtful clinical significance for children at low risk of persistent UTI following standard treatment. They recommend that clinicians decide on what duration of antibiotic treatment to use based on this risk, which is low (1?3 per cent) among children with their first UTI, but is higher (up to 14 per cent) among children who have recurrent UTIs.

The researchers conclude that short duration treatment would be a reasonable option for children at low risk of persistent infection.

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20007515

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.